That's crucial, since the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (jeff brown genetic sequencing stock). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're developed to do. This was an advancement practically nobody noticed. However it's going to have profound ramifications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown stock predictions). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it drew back maybe considerably prior to going higher - jeff brown genetic sequencing stock. I've been covering bitcoin for a very long time now. Among the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mostly educating readers. But that's not the big question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown biotech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many great personal business on the edge of hitting the public markets And I've been dealing with a new method for you to invest even prior to these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the information. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (jeff brown biotech stocks). And when it comes to tech investing, we leave it to the professionals. Fortunately, we have numerous such experts in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we know (diplomatic relations). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential development and developing extraordinary chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. exponential growth. However despite what numerous readers may think, this is a pattern that's just starting. Although the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (second wave). Losing 2 months of production and sales actually impacts how many 5G devices are offered in the fiscal year. When you consider all of that, selling 250 million units is amazing. More significantly, the hold-ups triggered by the pandemic created a heap of pent-up need. And that need is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - biotech stocks. And that's not my only 5G prediction When I've discussed 5G in the past, I've described its three different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Stage Three, 5G services begin to be provided (brownstone research). That's when we begin to see applications running on 5G networks. Think about things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer season. This begins something of a virtuous cycle: Many people don't really care about the innovation. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next essential technology I visualize in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR uses a similar concept however with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were truly just 3 companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is successfully a greenfield chance.
There's room for many companies to exist in this space. jeff brown stock market prediction. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is necessary because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug therapies produced using this innovation. This was one of those advancements that practically nobody saw. However it's going to have extensive ramifications for curing disease. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe significantly prior to going higher. I've been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - social media. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. the legacy report prediction. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we could not individually confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an exceptional point of view on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding credibility as a stock-picker, and he effectively forecasted a few of the most significant economic occasions of the previous twenty years. Although he does not appear to release his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, but Jeff Brown's precise predictions have earned him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research study uses a number of research study services with a variety of specializations - jeff brown 2021 stock predictions.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - jeff brown 2021 stock predictions. On its site, Brownstone states its mission is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research study has actually not been offered to individual investors. It has actually been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown tech stock 2021. The objective of Brownstone Research study is to make that type of proprietary research offered to any investors wanting to gain an edge in the markets. The goal is basic to deliver unique and rewarding investment research study discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise serves as the firm's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown biotech picks. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In fact, Brown thinks S.A.V. jeff brown predictions for 2021. could be "the greatest trend of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding two advanced technologies: expert system and electrical vehicles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars and trucks ever. It's nothing brief of the automotive industry's Holy Grail. As you understand, electric cars and self-driving automobile stocks have been huge this year, but the Wall Street maker has been huge on hype without much concrete outcome. Regardless of a drastic boost in competition over the past couple of years, Brown still thinks Musk has the very best opportunity of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Car, and it could be the future of transportation. Essentially, this technology would enable you to lease your automobile as a self-governing, self-driving taxi when you're not utilizing it. You merely leave the automobile and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the profits. It sounds ridiculous, but it might be closed than you believe.